An interventional study of Wearable posture corrector device in This Study Aims to Examine the Effect of a Wearable Posture Corrector Device on Back Pain Body Image and Postural Awareness in Young Adult Women, sponsored by Pamukkale University. Not yet recruiting. Open to female participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Pamukkale University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Pain by Pamukkale University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Pamukkale University.
Among the 15 studies in Pain by Pamukkale University, this one is the 2nd largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 14th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →3 of the 15 studies in Pain by Pamukkale University are open now, in 1 country. Recruiting first, the newest first:
Pamukkale University · Sites in Turkey
Ages 32 wk–34 wk
Pamukkale University · Sites in Turkey
Ages 18–65
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 25 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 52 across the 15 interventional studies. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Pamukkale University is the lead sponsor of 343 studies on the registry; 61 are open to participants now.
2 of the studies in Pain by Pamukkale University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07839169Pamukkale UniversityEffects of SIS Therapy in Individuals With Chronic Nonspecific Low Back Pain | 2026-12-30 |
| NCT07816952Pamukkale UniversityYoung Adult Women and Wearable Posture Corrector Device | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Pain by Pamukkale University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To improve posture, methods such as strengthening specific muscles or focusing on body alignment are commonly used. In addition to elastic posture correctors, electronic posture reminders can also be utilized. Thanks to current wearable technologies and their companion mobile apps, individuals can enhance their posture awareness. Although studies show that wearable technologies effectively foster posture awareness, the effects of wearable posture-correcting devices on back pain (VAS) and body image are not sufficiently known. This study aims to examine the effects of a wearable posture-correcting device on back pain, body image, and posture awareness to improve posture in young adult women.
This study is a randomized controlled experimental trial with pretest-posttest measurements in experimental and control groups. The study will be conducted with young adult female students. The sample size was calculated using the G*Power software, based on a similar study that utilized the same scale (VAS). In the a priori power analysis, based on an independent samples t-test with 80% power, an alpha level of 0.05, and an effect size of 0.56, a total of 82 participants-41 in the experimental group and 41 in the control group-were required. Considering potential sample dropouts, the sample size was increased by at least 10% and finalized at a total of 90 participants.Female participants who apply to join the study, express their willingness to use the wearable posture-correcting device, and meet the inclusion criteria will be randomly assigned to the experimental and control groups according to their order of application. Data will be collected using an 'Introductory Information Form', the 'VAS' to assess back pain, the 'Body Image Scale', and the 'Postural Awareness Scale'.Data analysis will be performed using the SPSS 31.0 software package. The test of significance of the difference between two means (independent samples t-test) will be utilized to reveal the differences between the two independent groups. A significance level of alpha 0.05 will be accepted.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A pretest will be administered to all participating women using the 'Introductory Information Form', the 'VAS' to evaluate back pain, the 'Body Image Scale' , and the 'Postural Awareness Scale'. Women in the experimental group will be provided with the wearable posture corrector device and instructed on how to use it. Following the completion of the intervention period, the posttest will be conducted by re-administering the 'VAS', 'Body Image Scale', and 'Postural Awareness Scale' to the experimental group.
Device: Wearable posture corrector device
No intervention will be administered to the control group, and data will be collected using the same measurement instruments at the same time points.
The planned device is designed for general use, requires no prescription, does not serve a clinical diagnostic or therapeutic purpose, and can be used without the need to consult a healthcare professional. The device is placed on the upper back during use. When the user assumes an incorrect posture, the device emits gentle vibrations to alert them, thereby promoting posture awareness. Women in the experimental group will use the device for a total of 4 weeks.
'Introductory Information Form'
This form, prepared by the researchers in accordance with the literature, consists of 9 questions containing the sociodemographic data of women.
Time frame: Baseline
VAS (Back Pain)
It is a single-item, non-invasive, universally used visual analog measurement tool designed to determine pain perception. It consists of a 100 mm horizontal line, numbered from 0 representing 'no pain' to 10 representing 'unbearable pain' at either end to indicate the severity of symptoms.
Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks
Body Image Scale
The 'Body Image Scale' was developed by Saylan \& Soyyiğit (2022) to evaluate body image in individuals during adolescence and emerging adulthood and was reported to be a valid and reliable instrument. It is a 5-point Likert-type scale (1 = Strongly disagree to 5 = Strongly agree) consisting of 21 items. It comprises four subdimensions: negative body perception, evaluation sensitivity, positive body perception, and body modification. Five items of the scale (Items 4, 7, 15, 16, and 17) are reverse-scored, with the total score ranging from a minimum of 21 to a maximum of 105. Higher scores obtained from the scale indicate a more negative body image.
Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks
Postural Awareness Scale
The Turkish validity and reliability of the Postural Awareness Scale was conducted by Dursun and Önen (2018). The purpose of the scale is to assess an individual's self-reported body posture awareness. It is a 7-point Likert-type scale (ranging from 1 = 'not at all true for me' to 7 = 'completely true for me') consisting of 11 items. Items 1, 2, 3, 4, 5, and 12 of the scale are reverse-scored, and the total score obtainable ranges from a minimum of 11 to a maximum of 77.
Time frame: It will be administered simultaneously to participants in both the experimental and control groups at baseline and 4-weeks
No study locations are listed for this record.
Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 7 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.